Viewing Study NCT01435369


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-01-04 @ 3:30 AM
Study NCT ID: NCT01435369
Status: COMPLETED
Last Update Posted: 2016-01-21
First Post: 2011-09-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma
Sponsor: Medivation, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module